# SJ733 Induced Blood Stage Malaria Challenge Study

> **NCT02867059** · PHASE1 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 17 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** (+)-SJ000557733

## Key facts

- **NCT ID:** NCT02867059
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-13
- **Primary completion:** 2016-12-22
- **Final completion:** 2016-12-22
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-05-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867059, "SJ733 Induced Blood Stage Malaria Challenge Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02867059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*